Univariate and multivariate analysis of freedom from treatment failure (FFTF). Univariate analysis was performed for all stages (column 2) and stratified according to the 3 treatment groups of the GHLSG (column 3)
Factor . | Univariate P-value . | Multivariate P-value . | ||
---|---|---|---|---|
Not Stratified . | Stratified3-150 . | All . | Selection . | |
Eosinos | .0001 | <.0001 | <.0001 | <.0001 |
Age | <.0001 | <.0001 | .0010 | .0006 |
Gender | .096 | .11 | .097 | .13 |
Karnofsky | <.0001 | <.0001 | .014 | .038 |
Stage3-151 | <.0001 | HD4 .23/HD5 .14/HD6 .0143-152 | .15 | — |
B symptoms | <.0001 | .11 | .41 | — |
Hist. subtype3-153 | .035 | .082 | .94 | — |
Extranodal | <.0001 | .0047 | .11 | .047 |
LMM | .65 | .65 | .40 | — |
ESR | <.0001 | .091 | .50 | .76 |
HB | <.0001 | .0002 | .084 | — |
Albumin | <.0001 | .0064 | .72 | — |
LDH | <.0001 | .056 | .034 | .16 |
AP | <.0001 | .12 | .18 | — |
Lymphocytes (blood) | .018 | .60 | .59 | — |
Factor . | Univariate P-value . | Multivariate P-value . | ||
---|---|---|---|---|
Not Stratified . | Stratified3-150 . | All . | Selection . | |
Eosinos | .0001 | <.0001 | <.0001 | <.0001 |
Age | <.0001 | <.0001 | .0010 | .0006 |
Gender | .096 | .11 | .097 | .13 |
Karnofsky | <.0001 | <.0001 | .014 | .038 |
Stage3-151 | <.0001 | HD4 .23/HD5 .14/HD6 .0143-152 | .15 | — |
B symptoms | <.0001 | .11 | .41 | — |
Hist. subtype3-153 | .035 | .082 | .94 | — |
Extranodal | <.0001 | .0047 | .11 | .047 |
LMM | .65 | .65 | .40 | — |
ESR | <.0001 | .091 | .50 | .76 |
HB | <.0001 | .0002 | .084 | — |
Albumin | <.0001 | .0064 | .72 | — |
LDH | <.0001 | .056 | .034 | .16 |
AP | <.0001 | .12 | .18 | — |
Lymphocytes (blood) | .018 | .60 | .59 | — |
Stratified according to treatment group, ie. early stage, intermediate stage, and advanced stage.
Four categories: stage I to stage IV (Ann-Arbor classification).
Separate P values for each strata: pooled value not available, since each stratum contains different stages.
(LP, LRCHD, and NS grade 1) versus (NS grade 2 and MC).
For multivariate testing (Cox-Model), 2 methods were used, including either all factors (“all”) or the selection of multivariate significant factors (“selection”), as described in “Materials and Methods.”
ESR: Erythrocyte sedimentation rate; LDH: lactate dehydrogenase; AP: alkaline phosphatase; LMM: large mediastinal mass.